BeiGene (BGNE) Should Be Up, Not Down - Maxim Group
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- S&P 500 muted as industrials counter tech drag; US-Iran peace prospects rise
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
Celgene Takeover Might Impact BeiGene's (BGNE) Tislelizumab Partnership - William Blair
January 3, 2019 2:17 PM ESTWilliam Blair analyst Katherine Xu notes the acquisition of Celgene by Bristol-Myers might impact BeiGene's (NASDAQ: BGNE) Tislelizumab partnership.
BeiGene and Celgene Corporation have a global strategic collaboration for the development of tislelizumab in solid tumors in the United States, Europe, Japan and the rest of world outside Asia.
... MoreBeiGene (BGNE) Sees Heavy Selling Pressure
January 3, 2019 9:57 AM ESTBeiGene (NASDAQ: BGNE) is under heavy pressure in early trade. Downside could be as a results of the Celgene/Bristol-Myers deal. Shares are down 17% on volume that is running 13x the norm.
... More